Table 2.
Viral Type | CIN I |
CIN II/III |
ICC |
Total | P Value |
---|---|---|---|---|---|
n=20 (%) | n=6 (%) | n=24 (%) | n=60 (%) | ||
16 | 2 (10) | 3 (18.75) | 8 (33.33) | 13 (21.67) | |
18 | 0 (0) | 1 (6.25) | 0 (0) | 1 (1.67) | |
31 | 0 (0) | 1 (6.25) | 0 (0) | 1 (1.67) | |
39 | 1 (5) | 0 (0) | 1 (4.17) | 2 (3.33) | |
45 | 0 (0) | 0 (0) | 3 (12.50) | 3 (5.0) | |
51 | 2(10) | 0 (0) | 0 (0) | 2 (3.33) | 0.165 |
58 | 1 (5) | 0 (0) | 0 (0) | 1 (1.67) | |
Multiple infection by HPV | |||||
HR | 5 (25) | 4(25) | 7(29.17) | 16(26.67) | |
HR + pHR | 4 (20) | 1 (6.25) | 0 (0) | 5(8.33) | |
HR + pHR + LR | 2 (10) | 0 (0) | 1 (4.2) | 3 (5) | |
HR + LR | 4 (20) | 4 (25) | 3(12.50) | 11 (18.33) | |
HR + IR | 0 (0) | 0 (0) | 1 (4.17) | 1 (1.67) | |
HR + X | 0 (0) | 1 (6.25) | 0 (0) | 1 (1.67) |
P value was calculated by Fisher’s exact test. Abbreviations: HPV, human papillomavirus; CIN, cervical intraepithelial neoplasia; ICC, invasive cervical carcinoma; HR, high risk; pHR, probable HR; LR, low risk; IR, intermediate risk; X, unidentified viral type by INNO-LiPA.